Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Verkauf | 87,03 | 2.474 | 215.312 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Optionsausübung | 39,42 | 2.474 | 97.525 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Verkauf | 86,32 | 10.090 | 870.969 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Verkauf | 85,35 | 8.786 | 749.885 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Optionsausübung | 38,10 | 18.876 | 719.176 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Verkauf | 86,34 | 385 | 33.241 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Verkauf | 85,28 | 426 | 36.329 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 06.07.2026 | Optionsausübung | 38,10 | 811 | 30.899 | Form 4 |
| PB | Franklin Robert R Jr | Vice Chairman | 06.07.2026 | Zuteilung | — | 25.000 | — | Form 4 |
| PBF | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | 06.07.2026 | Verkauf | 49,52 | 150.000 | 7.428.165 | Form 4 |
| PBF | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | 06.07.2026 | Verkauf | 48,00 | 50.000 | 2.400.045 | Form 4 |
| PRTH | Crisafulli Marc A | Director | 01.07.2026 | Optionsausübung | — | 4.296 | — | Form 4 |
| PRTH | Favilla Christina M | Director | 01.07.2026 | Verkauf | 6,67 | 1.229 | 8.197 | Form 4 |
| PRTH | Favilla Christina M | Director | 01.07.2026 | Optionsausübung | — | 4.296 | — | Form 4 |
| PRTH | Passilla Michael | Director | 01.07.2026 | Verkauf | 6,67 | 1.168 | 7.791 | Form 4 |
| PRTH | Passilla Michael | Director | 01.07.2026 | Optionsausübung | — | 4.296 | — | Form 4 |
| PRTH | Davis Marietta | Director | 01.07.2026 | Verkauf | 6,67 | 1.168 | 7.791 | Form 4 |
| PRTH | Davis Marietta | Director | 01.07.2026 | Optionsausübung | — | 4.296 | — | Form 4 |
| PRTH | Main Clayton James | Director | 01.07.2026 | Optionsausübung | — | 4.296 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 11.06.2026 | Verkauf | 7,10 | 10.000 | 70.950 | Form 4 |
| PAYS | Mina Bruce A | Director | 01.06.2026 | Verkauf | 7,10 | 10.000 | 71.000 | Form 4 |
| PAYS | Triplett Dennis L | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Newman Jeffrey B | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PAYS | Henry Daniel R | Director | 08.05.2026 | Zuteilung | — | 20.000 | — | Form 4 |
| PLBY | Bernhard L Kohn III | CEO | 24.04.2026 | Verkauf | 1,83 | 18.502 | 33.859 | Form 4 |
| PLBY | Christopher Riley | General Counsel | 24.04.2026 | Verkauf | 1,82 | 8.916 | 16.227 | Form 4 |
| PMI | Michael Patrick O'Shea | Insider | 24.04.2026 | Kauf | — | 4.463 | — | — |
| PMI | Piers Godfrey Harrison | Insider | 24.04.2026 | Kauf | — | 4.463 | — | — |
| PCRX | Shawn Cross | CFO | 23.04.2026 | Verkauf | 25,16 | 12.941 | 325.596 | Form 4 |
| PEBK | James S Abernethy | Director | 23.04.2026 | Verkauf | 40,06 | 600 | 24.036 | Form 4 |
| PHVS | Anne Lesage | Insider | 23.04.2026 | Verkauf | 30,03 | 100 | 3.003 | Form 4 |
| PHVS | Johannes Gerardus Chri Schikan | Director | 23.04.2026 | Verkauf | 30,03 | 100 | 3.003 | Form 4 |
| PHVS | Peng Lu | Insider | 23.04.2026 | Verkauf | 30,03 | 100 | 3.003 | Form 4 |
| P | John Colgrove | Insider | 23.04.2026 | Verkauf | 70,06 | 71.959 | 5.041.448 | Form 4 |
| PCRX | Shawn Cross | CFO | 22.04.2026 | Verkauf | 25,01 | 1.500 | 37.515 | Form 4 |
| PAHC | Jack Bendheim | CEO | 22.04.2026 | Verkauf | 54,29 | 7.040 | 382.202 | Form 4 |
| PB | Ned S Holmes | Director | 22.04.2026 | Verkauf | 69,86 | 500 | 34.930 | Form 4 |
| PB | Ned S Holmes | Director | 22.04.2026 | Verkauf | 69,85 | 600 | 41.910 | Form 4 |
| PAM | Marcos Marcelo Mindlin | Director | 22.04.2026 | Verkauf | 3,51 | 1.500.000 | 5.265.000 | Form 4 |
| PHVS | Anne Lesage | Insider | 22.04.2026 | Verkauf | 30,05 | 7.500 | 225.375 | Form 4 |
| PHVS | Anne Lesage | Insider | 22.04.2026 | Verkauf | 30,05 | 7.000 | 210.350 | Form 4 |
| PHVS | Johannes Gerardus Chri Schikan | Director | 22.04.2026 | Verkauf | 30,05 | 7.000 | 210.350 | Form 4 |
| PHVS | Peng Lu | Insider | 22.04.2026 | Verkauf | 30,05 | 7.001 | 210.380 | Form 4 |
| PMN | Patrick D Kirwin | Director | 22.04.2026 | Kauf | 11,33 | 4.000 | 45.320 | Form 4 |
| PENG | Anne Kuykendall | SVP | 22.04.2026 | Verkauf | 27,92 | 738 | 20.605 | Form 4 |
| P | John Colgrove | Insider | 22.04.2026 | Verkauf | 70,50 | 82.266 | 5.799.753 | Form 4 |
| PBI | Lauren Freemen-Bosworth | EVP | 21.04.2026 | Verkauf | 14,25 | 169 | 2.408 | Form 4 |
| PTCT | Matthew B Klein | CEO | 21.04.2026 | Verkauf | 70,91 | 2.850 | 202.094 | Form 4 |
| PCRX | Shawn Cross | CFO | 21.04.2026 | Verkauf | 25,01 | 2.845 | 71.153 | Form 4 |
| PLMR | Mac Armstrong | CEO | 21.04.2026 | Verkauf | 130,77 | 3.500 | 457.695 | Form 4 |
| PRLD | David P Bonita | Director | 21.04.2026 | Kauf | 4,44 | 2.815.315 | 12.499.999 | Form 4 |
| PRLD | Orbimed Advisors Llc | Director | 21.04.2026 | Kauf | 4,44 | 2.815.315 | 12.499.999 | Form 4 |
| PRCH | Matt Ehrlichman | CEO | 21.04.2026 | Verkauf | 8,12 | 121.242 | 984.485 | Form 4 |
| PRCH | Matthew Neagle | COO | 21.04.2026 | Verkauf | 8,12 | 62.801 | 509.944 | Form 4 |
| PRCH | Shawn Tabak | CFO | 21.04.2026 | Verkauf | 8,12 | 7.730 | 62.768 | Form 4 |
| P | John Colgrove | Insider | 21.04.2026 | Verkauf | 70,06 | 16.840 | 1.179.810 | Form 4 |
| PCRX | Shawn Cross | CFO | 20.04.2026 | Verkauf | 25,14 | 7.714 | 193.930 | Form 4 |
| PAM | Marcos Marcelo Mindlin | Director | 20.04.2026 | Verkauf | 3,43 | 1.250.000 | 4.287.500 | Form 4 |
| PTGX | Asif Ali | CFO | 20.04.2026 | Verkauf | 105,47 | 1.750 | 184.573 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).